Kidney cancers originate from kidney tissue and represent an important group of diseases within urological oncology. In many cases, the disease may not cause symptoms in the early stages and can be detected incidentally during imaging studies performed for other reasons.
In more advanced stages, symptoms such as lower back pain, blood in the urine, a palpable mass, fatigue, and weight loss may occur. Therefore, early diagnosis is critical for successful treatment outcomes in kidney cancers.
Diagnosis and Evaluation Process
Imaging methods play a central role in the diagnosis of kidney cancers. Ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are used to evaluate the size, location, and relationship of the renal mass with surrounding tissues in detail.
When necessary, additional tests may be performed to assess disease spread. Based on this evaluation, the tumor type and stage are determined, and treatment planning is carried out.
Treatment Approach
Treatment of kidney cancers is planned according to the tumor stage, size, location, and the patient’s overall health status. Surgical treatment constitutes the primary treatment option in many cases. In suitable patients, minimally invasive surgical approaches may also be considered.
The main goals of treatment are to effectively remove cancerous tissue, preserve kidney function as much as possible, and achieve disease control.
Post-Treatment Follow-up
After surgical or other treatment approaches, patients are enrolled in a regular follow-up program. The course of the disease is monitored through imaging studies and clinical evaluations.
This follow-up process is crucial for early detection of recurrence and for achieving long-term healthy outcomes.
